Pathophysiology of exacerbations of chronic obstructive pulmonary disease
- PMID: 16636093
- DOI: 10.1513/pats.200512-125SF
Pathophysiology of exacerbations of chronic obstructive pulmonary disease
Abstract
Smokers with stable chronic obstructive pulmonary disease have a chronic inflammation of the entire tracheobronchial tree characterized by an increased number of macrophages and CD8 T lymphocytes in the airway wall and of neutrophils in the airway lumen. Exacerbations of chronic obstructive pulmonary disease are considered to reflect worsening of the underlying chronic inflammation of the airways, caused mainly by viral and bacterial infections and air pollution. During exacerbations, the inflammatory cellular pattern changes, with a further increase of eosinophils and/or neutrophils and various inflammatory mediators--for example, cytokines (tumor necrosis factor-alpha, RANTES [regulated upon activation normal T cell-expressed and secreted], and eotaxin-1), chemokines (CXCL5 [ENA-78], CXCL8), chemokine receptors (CCR3, CXCR1, and CXCR2), adhesion molecules (E-selectin and ICAM-1), and markers of oxidative stress (H(2)O(2) and 8-isoprostane, glutathione depletion). Worsening of inflammation is considered responsible for the deterioration of lung function and clinical status during exacerbations.
Similar articles
-
Cytokines in chronic obstructive pulmonary disease.Eur Respir J Suppl. 2001 Dec;34:50s-59s. Eur Respir J Suppl. 2001. PMID: 12392035 Review.
-
Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations.Am J Respir Crit Care Med. 2006 May 15;173(10):1114-21. doi: 10.1164/rccm.200506-859OC. Epub 2006 Feb 16. Am J Respir Crit Care Med. 2006. PMID: 16484677
-
The role of bacteria in airway inflammation in exacerbations of chronic obstructive pulmonary disease.Curr Opin Infect Dis. 2006 Jun;19(3):225-30. doi: 10.1097/01.qco.0000224815.89363.15. Curr Opin Infect Dis. 2006. PMID: 16645482 Review.
-
Oxidative stress and airway inflammation in severe exacerbations of COPD.Thorax. 2005 Apr;60(4):293-300. doi: 10.1136/thx.2004.027946. Thorax. 2005. PMID: 15790984 Free PMC article.
-
Exacerbations of chronic obstructive pulmonary disease.Respir Care. 2003 Dec;48(12):1204-13; discussion 1213-5. Respir Care. 2003. PMID: 14651761 Review.
Cited by
-
Redox-active antioxidant modulation of lipid signaling in vascular endothelial cells: vitamin C induces activation of phospholipase D through phospholipase A2, lipoxygenase, and cyclooxygenase.Mol Cell Biochem. 2008 Aug;315(1-2):97-112. doi: 10.1007/s11010-008-9793-6. Epub 2008 May 22. Mol Cell Biochem. 2008. PMID: 18496733 Free PMC article.
-
The Th17/Treg Cytokine Imbalance in Chronic Obstructive Pulmonary Disease Exacerbation in an Animal Model of Cigarette Smoke Exposure and Lipopolysaccharide Challenge Association.Sci Rep. 2019 Feb 13;9(1):1921. doi: 10.1038/s41598-019-38600-z. Sci Rep. 2019. PMID: 30760822 Free PMC article.
-
The Relationship Between Prognostic Nutritional Indexes and the Clinical Outcomes of Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.Int J Chron Obstruct Pulmon Dis. 2023 Jun 12;18:1155-1167. doi: 10.2147/COPD.S402717. eCollection 2023. Int J Chron Obstruct Pulmon Dis. 2023. PMID: 37332836 Free PMC article.
-
Paradigms in chronic obstructive pulmonary disease: phenotypes, immunobiology, and therapy with a focus on vascular disease.J Investig Med. 2017 Aug;65(6):953-963. doi: 10.1136/jim-2016-000358. Epub 2017 Mar 3. J Investig Med. 2017. PMID: 28258130 Free PMC article. Review.
-
Selective inhibition by simvastatin of IRF3 phosphorylation and TSLP production in dsRNA-challenged bronchial epithelial cells from COPD donors.Br J Pharmacol. 2013 Jan;168(2):363-74. doi: 10.1111/j.1476-5381.2012.02131.x. Br J Pharmacol. 2013. PMID: 22881993 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous